We found that the levels of HIF-1α were reduced in ALL cells treated with DFO, and prolyl hydroxylase domain enzyme-2 (PHD-2) expression was increased, whose effects were reversed by Dex treatment. Here, HIF1A is linked to acute lymphoblastic leukemia.